|
AU3861397A
|
|
Controlled release tablet formulation of isosorbide-5-mononitrate
|
|
IE960540A1
|
|
A formulation
|
|
WO9704758A1
|
|
Pharmaceutical preparation for percutaneous absorbtion
|
|
IE960539A1
|
|
Pharmaceutical preparation for percutaneous absorbtion
|
|
WO9704757A1
|
|
Transdermal nitrate formulation
|
|
AU6708896A
|
|
Cardioactive aspirinates
|
|
EP0840600A1
|
|
Transdermal patch containing aspirin
|
|
IE950062A1
|
|
A pharmaceutical product
|
|
GB9616298D0
|
|
Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
|
|
AU1670995A
|
|
A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
|
|
IE950063A1
|
|
A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
|
|
AU4581293A
|
|
Esters of an organic nitrate and a salicylate
|
|
CA2141404A1
|
|
Combinations of an organic nitrate and a salicylate
|
|
IE930562A1
|
|
Combinations of an organic nitrate and a salicylate
|
|
GB9501985D0
|
|
Pharmaceutical capsule containing an organic nitrate and a salicylate
|
